Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taha Merghoub

Showing results (171-180 of 216) with videos related to

Pageof 22
Sort By:
Plos One|April 5, 2018
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibodyRandi B Gombos, Ana Gonzalez, Mariana Manrique, et al.
Nature Immunology|July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Immunology|September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Genetics|June 30, 2025
Disruption of TAD hierarchy promotes LTR co-option in cancerElissa W P Wong, Merve Sahin, Rui Yang, et al.
Immunity|June 8, 2021
Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8<sup>+</sup> T cells in tumorsShihao Xu, Omkar Chaudhary, Patricia Rodríguez-Morales, et al.
Cell Metabolism|January 17, 2017
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor GrowthSiyuan Xia, Ruiting Lin, Lingtao Jin, et al.
Journal for Immunotherapy of Cancer|September 15, 2020
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancerJoshua E Reuss, Valsamo Anagnostou, Tricia R Cottrell, et al.
Nature|May 19, 2022
Neoantigen quality predicts immunoediting in survivors of pancreatic cancerMarta Łuksza, Zachary M Sethna, Luis A Rojas, et al.
Nature Communications|September 9, 2022
In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy responseAditi Sahu, Kivanc Kose, Lukas Kraehenbuehl, et al.
Cancer Research|July 10, 2020
Leveraging Systematic Functional Analysis to Benchmark an <i>In Silico</i> Framework Distinguishes Driver from Passenger MEK Mutants in CancerAphrothiti J Hanrahan, Brooke E Sylvester, Matthew T Chang, et al.
Pageof 22

Showing results (171-180 of 216) with videos related to

Sort By:
Pageof 22
Plos One|April 5, 2018
Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibodyRandi B Gombos, Ana Gonzalez, Mariana Manrique, et al.
Nature Immunology|July 31, 2019
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Immunology|September 26, 2019
Author Correction: PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1<sup>+</sup>CD38<sup>hi</sup> cells and anti-PD-1 resistanceVivek Verma, Rajeev K Shrimali, Shamim Ahmad, et al.
Nature Genetics|June 30, 2025
Disruption of TAD hierarchy promotes LTR co-option in cancerElissa W P Wong, Merve Sahin, Rui Yang, et al.
Immunity|June 8, 2021
Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8<sup>+</sup> T cells in tumorsShihao Xu, Omkar Chaudhary, Patricia Rodríguez-Morales, et al.
Cell Metabolism|January 17, 2017
Prevention of Dietary-Fat-Fueled Ketogenesis Attenuates BRAF V600E Tumor GrowthSiyuan Xia, Ruiting Lin, Lingtao Jin, et al.
Journal for Immunotherapy of Cancer|September 15, 2020
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancerJoshua E Reuss, Valsamo Anagnostou, Tricia R Cottrell, et al.
Nature|May 19, 2022
Neoantigen quality predicts immunoediting in survivors of pancreatic cancerMarta Łuksza, Zachary M Sethna, Luis A Rojas, et al.
Nature Communications|September 9, 2022
In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy responseAditi Sahu, Kivanc Kose, Lukas Kraehenbuehl, et al.
Cancer Research|July 10, 2020
Leveraging Systematic Functional Analysis to Benchmark an <i>In Silico</i> Framework Distinguishes Driver from Passenger MEK Mutants in CancerAphrothiti J Hanrahan, Brooke E Sylvester, Matthew T Chang, et al.
Pageof 22